Home

What we want to achieve

H2HCare will sustain and improve the quality of life of older adults helping them to better cope with and self-manage transitional care problems in case of heart failure avoiding hospital readmissions.

H2HCare in short

What We Do

Pre-Discharge Comprehensive Elders Risk Assessment Service

will help doctors to determine the readmission risks associated with each older adult patient by conducting a comprehensive “whole-person” assessment and to configure and personalise the robot-based intervention accordingly

Older Adult Post-Discharge Monitoring and
Follow-up Service

will use sensors and artificial intelligence to monitor and detect daily life activities that are not in line with the post-discharge treatment, care recommendations and medication plan

Robot-based Coaching and Intervention Service

provides timely intervention through personalised care and coordinated guidance and motivation for the older adults’ patients and associated informal caregivers to adhere to the post-discharge treatment recommendations

Updates

From Our Blog

  • H2Hcare project ending
    The H2Hcare project aimed to develop a digital assistance platform that integrates Internet of Things (IoT) devices, machine learning and a digital assistant to support elderly people with heart failure in their transition from hospital discharge to home care. TheContinue reading “H2Hcare project ending”
  • ICCP2023 paper submission
    H2HCare paper submitted to 2023 IEEE 19th International Conference on Intelligent Computer Communication and Processing (ICCP 2023), to be held October 26-28, 2023 in Cluj-Napoca, Romania: Title: A Machine Learning based Platform for Remote Management of Heart Failure Patients Abstract:Continue reading “ICCP2023 paper submission”
  • Field trials closed
    The H2HCare final trials in Switzerland have been closed. The consortium is preparing the final project deliverable with evaluation feedback and suggestions from end-users. As an early feedback, the system has been well received by all users, and they allContinue reading “Field trials closed”
More blog posts